Regional cerebral blood flow reductions, heart failure and Alzheimer's disease

Neurological Research

Volumn 28, Issue 6, 2006, Pages 579-587

  De Toledo Ferraz Alves, Tânia Corrêa ^a   Busatto, Geraldo F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer's disease; Cerebral blood flow; Cognition; Heart failure; Neuroimage

Indexed keywords

CAPTOPRIL; CARBON DIOXIDE; ENALAPRIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; XENON 133;

AGED; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; GLUCOSE METABOLISM; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMAGE ANALYSIS; MAJOR DEPRESSION; MEMORY DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SCINTIANGIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ALZHEIMER DISEASE; CEREBROVASCULAR CIRCULATION; HEART FAILURE, CONGESTIVE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33748951914     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X130416     Document Type: Review

References (115)

1. Zambroski CH. Qualitative analysis of living with heart failure. Heart Lung 2003; 32: 32-40
2. Zuccala G, Pedone C, Cesari M, et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003; 115: 97-103
3. Almeida OP, Flicker L. The mind of a failing heart: A systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001; 31: 290-295
4. Antonelli Incalzi R, Trojano L, Acanfora D, et al. Verbal memory impairment in congestive heart failure. J Clin Exp Neuropsychol 2003; 25: 14-23
5. Ackerman RH. Cerebral blood flow and neurological change in chronic heart failure. Stroke 2001; 32: 2462-2464
6. Gruhn N, Larsen FS, Boesgaard S, et al. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001; 32: 2530-2533
7. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-190
8. de la Torre JC. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann NY Acad Sci 2000; 924: 136-152
9. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64: 575-611
10. de la Torre JC. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Biobehav Rev 1994; 18: 397-401
11. Gungor HA, Yildiz A, Aydin F, et al. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: Correlation with event related potentials. J Neurol Sci 2005; 234: 47-53
12. Busatto GF, Garrido GE, Almeida OP, et al. A voxel-based morphometry study of temporal lobe gray matter reductions in Alzheimer's disease. Neurobiol Aging 2003; 24: 221-231
13. Garrido GE, Furuie SS, Buchpiguel CA, et al. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: A combined MRI and SPECT study. J Neurol Neurosurg Psychiatry 2002; 73: 508-516
14. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 2001; 15: 85-92
15. Bottino CM, Castro CC, Gomes RL, et al. Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging. Int Psychogeriatr 2002; 14: 59-72
16. Kantarci K, Jack CR, Jr. Neuroimaging in Alzheimer disease: An evidence-based review. Neuroimaging Clin N Am 2003; 13: 197-209
17. Laukka EJ, Jones S, Small BJ, et al. Similar patterns of cognitive deficits in the preclinical phases of vascular dementia and Alzheimer's disease. J Int Neuropsychol Soc 2004; 10: 382-391
18. Borroni B, Anchisi D, Paghera B, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006; 27: 24-31
19. Nobili F, Brugnolo A, Calvini P, et al. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. Clin Neurophysiol 2005; 116: 364-375
20. Reiman EM, Chen K, Alexander GE, et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 2005; 102: 8299-8302
21. Hirao K, Ohnishi T, Hirata Y, et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005; 28: 1014-1021
22. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 2005; 32: 486-510
23. Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol 2006; 100: 328-335
24. van der Flier WM, Middelkoop HA, Weverling-Rijnsburger AW, et al. Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology 2004; 62: 1862-1864
25. Sadowski M, Pankiewicz J, Scholtzova H, et al. Links between the pathology of Alzheimer's disease and vascular dementia. Neurochem Res 2004; 29: 1257-1266
26. Weller RO, Nicoll JA. Cerebral amyloid angiopathy: Pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 2003; 25: 611-616
27. Wais PE, Wixted JT, Hopkins RO, et al. The hippocampus supports both the recollection and the familiarity components of recognition memory. Neuron 2006; 49: 459-466
28. Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. J Cogn Neurosci 2000; 12: 1-47
29. Muller MJ, Greverus D, Dellani PR, et al. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. NeuroImage 2005; 28: 1033-1042
30. Chetelat G, Landeau B, Eustache F, et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: A longitudinal MRI study. Neuroimage 2005; 27: 934-946
31. Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004; 56: 27-35
32. Mungas D, Reed BR, Jagust WJ, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002; 59: 867-873
33. Zakzanis KK, Graham SJ, Campbell Z. A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: A neuroimaging profile. Neuropsychol Rev 2003; 13: 1-18
34. Ylikoski R, Salonen O, Mantyla R, et al. Hippocampal and temporal lobe atrophy and age-related decline in memory. Acta Neurol Scand 2000; 101: 273-278
35. Grundman M, Sencakova D, Jack CR, Jr., et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci 2002; 19: 23-27
36. Matsuda H, Kanetaka H, Ohnishi T, et al. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur J Nucl Med Mol Imaging 2002; 29: 1502-1505
37. Mielke R, Heiss WD. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia. J Neural Transm Suppl 1998; 53: 237-250
38. Kerrouche N, Herholz K, Mielke R, et al. (18)FDG PET in vascular dementia: Differentiation from Alzheimer's disease using voxel-based multivariate analysis. J Cereb Blood Flow Metab 2006;
39. Nagata K, Maruya H, Yuya H, et al. Can PET data differentiate Alzheimer's disease from vascular dementia? Ann NY Acad Sci 2000; 903: 252-261
40. Testa C, Laakso MP, Sabattoli F, et al. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease. J Magn Reson Imaging 2004; 19: 274-282
41. Colloby SJ, O'Brien JT, Fenwick JD, et al. The application of statistical parametric mapping to 1231-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage 2004; 23: 956-966
42. Varrone A, Pappata S, Caraco C, et al. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks. Eur J Nucl Med Mol Imaging 2002; 29: 1447-1454
43. Ishii K, Sasaki M, Yamaji S, et al. Demonstration of decreased posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography. Eur J Nucl Med 1997; 24: 670-673
44. Liao YC, Liu RS, Lee YC, et al. Selective hypoperfusion of anterior cingulate gyrus in depressed AD patients: A brain SPECT finding by statistical parametric mapping. Dement Geriatr Cogn Disord 2003; 16: 238-244
45. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992
46. Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; 101: 284-289
47. Reiman EM, Uecker A, Caselli RJ, et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998; 44: 288-291
48. Mosconi L, Sorbi S, Nacmias B, et al. Age and ApoE genotype interaction in Alzheimer's disease: An FDG-PET study. Psychiatry Res 2004; 130: 141-151
49. Hoffman JM, Welsh-Bohmer KA, Hanson M, et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med 2000; 41: 1920-1928
50. Desgranges B, Baron JC, de la Sayette V, et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain 1998; 121 (Pt 4): 611-631
51. Desgranges B, Baron JC, Giffard B, et al. The neural basis of intrusions in free recall and cued recall: A PET study in Alzheimer's disease. Neuroimage 2002; 17: 1658-1664
52. Kessler RM. Imaging methods for evaluating brain function in man. Neurobiol Aging 2003; 24 (Suppl. 1): S21-S35
53. Jonsson C, Pagani M, Ingvar M, et al. Resting state rCBF mapping with single-photon emission tomography and positron emission tomography: Magnitude and origin of differences. Eur J Nucl Med 1998; 25: 157-165
54. Kogure D, Matsuda H, Ohnishi T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41: 1155-1162
55. Woo MA, Macey PM, Fonarow GC, et al. Regional brain gray matter loss in heart failure. J Appl Physiol 2003; 95: 677-684
56. Woo MA, Macey PM, Keens PT, et al. Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure. J Card Fail 2005; 11: 437-446
57. Lee CW, Lee JH, Lim TH, et al. Prognostic significance of cerebral metabolic abnormalities in patients with congestive heart failure. Circulation 2001; 103: 2784-2787
58. Lee CW, Lee JH, Kim JJ, et al. Cerebral metabolic abnormalities in congestive heart failure detected by proton magnetic resonance spectroscopy. J Am Coll Cardiol 1999; 33: 1196-1202
59. Lassen NA, Larsen OA. Measurement of blood flow with freely diffusible indicators as inert gases, antipyrine, labelled water and rubidium. Acta Endocrinol Suppl (Copenh) 1972; 158: 95-111
60. Georgiadis D, Sievert M, Cencetti S, et al. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur Heart J 2000; 21: 407-413
61. Rajagopalan B, Raine AE, Cooper R, et al. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment. Am J Med 1984; 76: 86-90
62. Paulson OB, Jarden JO, Godtfredsen J, et al. Cerebral blood flow in patients with congestive heart failure treated with captopril. Am J Med 1984; 76: 91-95
63. Wanless RB, Anand IS, Poole-Wilson PA, et al. An experimental model of chronic cardiac failure using adriamycin in the rabbit: Central haemodynamics and regional blood flow. Cardiovasc Res 1987; 21: 7-13
64. Wanless RB, Anand IS, Gurden J, et al. Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: Effects of isosorbide dinitrate, dobutamine and captopril. J Pharmacol Exp Ther 1987; 243: 1101-1106
65. Costa DC, Verhoeff NP, Cullum ID, et al. In vivo characterisation of 3-iodo-6-methoxybenzamide 1231 in humans. Eur J Nucl Med 1990; 16: 813-816
66. Neirinckx RD. Evaluation of regional cerebral blood flow with 99mTc-d, 1 HM-PAO and SPECT. Neurosurg Rev 1987; 10: 181-184
67. Alves TC, Rays J, Fraguas R, Jr., et al. Localized cerebral blood flow reductions in patients with heart failure: A study using 99mTc-HMPAO SPECT. J Neuroimaging 2005; 15: 150-156
68. Zuccala G, Cattel C, Manes-Gravina E, et al. Left ventricular dysfunction: A clue to cognitive impairment in older patients with heart failure. J Neurol Neurosurg Psychiatry 1997; 63: 509-512
69. Grubb NR, Simpson C, Fox KA. Memory function in patients with stable, moderate to severe cardiac failure. Am Heart J 2000; 140: 1-5
70. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: 698-709
71. Almeida OP, Tamai S. Clinical treatment reverses attentional deficits in congestive heart failure. BMC Geriatr 2001; 1: 2
72. Pansari K, Gupta A, Thomas P. Alzheimer's disease and vascular factors: Facts and theories. Int J Clin Pract 2002; 56: 197-203
73. Polidori MC, Marvardi M, Cherubini A, et al. Heart disease and vascular risk factors in the cognitively impaired elderly: Implications for Alzheimer's dementia. Aging (Milano) 2001; 13: 231-239
74. Rafael H. Cerebral atherosclerosis and mild Alzheimer's disease. Stroke 2003; 34: e106
75. Honig LS, Tang MX, Albert S, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 2003; 60: 1707-1712
76. Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging 2005;
77. Solfrizzi V, Panza F, Colacicco AM, et al. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004; 63: 1882-1891
78. Schnaider Beeri M, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 2004; 63: 1902-1907
79. Roher AE, Esh C, Rahman A, et al. Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 2004; 35: 2623-2627
80. Corelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 2004; 35 (Suppl. 1): S2620-S2622
81. Wang L, Zang Y, He Y, et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: Evidence from resting state fMRI. Neuroimage 2006; 31: 496-504
82. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: Evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005; 25: 7709-7717
83. Blaizot X, Meguro K, Millien I, et al. Correlations between visual recognition memory and neocortical and hippocampal glucose metabolism after bilateral rhinal cortex lesions in the baboon: Implications for Alzheimer's disease. J Neurosci 2002; 22: 9166-9170
84. Chavoix C, Blaizot X, Meguro K, et al. Excitotoxic lesions of the rhinal cortex in the baboon differentially affect visual recognition memory, habit memory and spatial executive functions. Eur J Neurosci 2002; 15: 1225-1236
85. Millien I, Blaizot X, Giffard C, et al. Brain glucose hypometabolism after perirhinal lesions in baboons: Implications for Alzheimer disease and aging. J Cereb Blood Flow Metab 2002; 22: 1248-1261
86. Buckner RL. Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron 2004; 44: 195-208
87. Meguro K, Blaizot X, Kondoh Y, et al. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain 1999; 122 (Pt 8): 1519-1531
88. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319
89. Baron JC, Chetelat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001; 14: 298-309
90. Good CD, Scahill RI, Fox NC, et al. Automatic differentiation of anatomical patterns in the human brain: Validation with studies of degenerative dementias. Neuroimage 2002; 17: 29-46
91. Thompson PM, Hayashi KM, de Zubicaray G, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 2003; 23: 994-1005
92. Wang Y, Klunk WE, Debnath ML, et al. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease. J Mol Neurosci 2004; 24: 55-62
93. Farkas E, De Jong GI, Apro E, et al. Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link? Ann NY Acad Sci 2000; 903: 72-82
94. Farkas E, De Jong GI, de Vos RA, et al. Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease. Acta Neuropathol (Berl) 2000; 100: 395-402
95. Freedland KE, Rich MW, Skala JA, et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003; 65: 119-128
96. Thomas SA, Friedmann E, Khatta M, et al. Depression in patients with heart failure: Physiologic effects, incidence, and relation to mortality. AACN Clin Issues 2003; 14: 3-12
97. Junger J, Schellberg D, Muller-Tasch T, et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail 2005; 7: 261-267
98. Roose SP. Depression, anxiety, and the cardiovascular system: The psychiatrist's perspective. J Clin Psychiatry 2001; 62 (Suppl. 8): 19-22
99. Alves TC, Rays J, Telles RM, et al. Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid major depression: An exploratory study. Psychosomatics 2006; in press
100. Alves TC, Rays J, Fraguas Jr R, et al. Association between major depressive symptoms in heart failure and impaired regional cerebral blood flow in the medial temporal region: A study using 99m Tc-HMPAO single photon emission computerized tomography (SPECT). Psychol Med 2006; 36: 597-608
101. Campbell S, Marriott M, Nahmias C, et al. Lower hippocampal volume in patients suffering from depression: A meta-analysis. Am J Psychiatry 2004; 161: 598-607
102. Drevets WC, Price JL, Bardgett ME, et al. Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 2002; 71: 431-447
103. Phillips ML, Drevets WC, Rauch SL, et al. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 2003; 54: 515-528
104. Krishnan KR. Biological risk factors in late life depression. Biol Psychiatry 2002; 52: 185-192
105. O'Brien JT, Lloyd A, McKeith I, et al. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 2004; 161: 2081-2090
106. Seminowicz DA, Mayberg HS, McIntosh AR, et al. Limbic-frontal circuitry in major depression: A path modeling metanalysis. Neuroimage 2004; 22: 409-418
107. Marvel CL, Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin North Am 2004; 27: 19-36, vii-viii
108. Cummings JL. Alzheimer's disease: From molecular biology to neuropsychiatry. Semin Clin Neuropsychiatry 2003; 8: 31-36
109. Haan MN, Wallace R. Can dementia be prevented? Brain aging in a population-based context. Annu Rev Public Health 2004; 25: 1-24
110. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer's disease: Seeking the neurobiological basis. Neurobiol Aging 2000; 21: 845-861
111. Modrego PJ, Fayed N, Pina MA. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy. Am J Psychiatry 2005; 162: 667-675
112. Paulson OB, Jarden JO, Vorstrup S, et al. Effect of captopril on the cerebral circulation in chronic heart failure. Eur J Clin Invest 1986; 16: 124-132
113. Kamishirado H, Inoue T, Fujito T, et al. Effect of enalapril maleate on cerebral blood flow in patients with chronic heart failure. Angiology 1997; 48: 707-713
114. Massaro AR, Dutra KP, Almeida DR, et al. Transcranial Doppler assessment of cerebral blood flow: Effect of cardiac transplantation. Neurology 2006; 66: 124-126
115. Talairach J, Tornoux P. A Co-planaR Stereotaxic Atlas of Human Brain, Stuttgart, Germany: Thieme, 1988